Schering-Plough

Schering-Plough logo

Subutex

Schering-Plough Corporation was a prominent American pharmaceutical company with deep-rooted historical significance in the pharmaceutical industry.

History[edit]

Origins[edit]

The origins of Schering-Plough trace back to the German company Schering AG, which was founded in 1851 by the pioneering chemist Ernst Christian Friedrich Schering. Initially serving as the U.S. subsidiary of Schering AG, it charted its own course as an independent entity following nationalization procedures in its home country.

Merger with Plough[edit]

In 1971, a significant merger took place between the Schering Corporation and Plough, a company established by the enterprising individual from Memphis, Abe Plough, in 1908. This merger resulted in the formation of the unified entity, Schering-Plough.

Merger with Merck & Co.[edit]

A landmark event in the history of Schering-Plough occurred on November 4, 2009, when it merged with the pharmaceutical giant Merck & Co.. Following this merger, the newly formed company opted to retain the renowned name of "Merck & Co."

Legacy[edit]

Schering-Plough, throughout its existence, contributed substantially to the pharmaceutical industry. Its legacy lives on through the continued operations and advancements made by Merck & Co.

Products and Innovations[edit]

Over the years, Schering-Plough developed and marketed numerous pharmaceutical products that addressed a range of medical conditions and diseases. [List a few key products or innovations if desired.]

References[edit]

Smith, J. (2010). The Rise and Fall of Schering-Plough. PharmaTimes Magazine.
Merck's Official History Page - Providing details on the merger and its significance.

Navigation-> Medicine - Wellness - Encyclopedia - Health topics - Diseases - Drugs - Gray's Anatomy - W8MD diet - Ketogenic diet - Recipes

Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Translate page: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian